WELL Welltower Inc.

Welltower Announces Date of Fourth Quarter 2016 Earnings Release, Conference Call and Webcast

TOLEDO, Ohio--(BUSINESS WIRE)--

Welltower Inc. (NYSE:HCN) today announced that it will release its fourth quarter 2016 financial results before the market opens on February 22, 2017. The company will also host a conference call on February 22, 2017 at 10:00 a.m. Eastern Time to discuss these results. The company’s earnings release will be available in the Investors section of the company’s website.

Investors and other interested parties may access the conference call in the following ways:

  • At the company’s website: www.welltower.com. To participate in the webcast, please log on 15 minutes in advance of the scheduled call to download the necessary software. A webcast replay will be available approximately two hours after the conference call concludes and will be available for 90 days.
  • By telephone: The telephone dial-in number in the U.S. is 888-346-2469. For participants outside the U.S., the dial-in number is 706-758-4923. The conference ID number is 55892518.
  • A replay of the conference call will be available beginning at approximately 1:00 p.m. on February 22, 2017, and ending on March 8, 2017. The replay dial-in number for U.S. participants is 855-859-2056. For participants outside the U.S., the replay dial-in number is 404-537-3406. The replay conference ID number is 55892518.

About Welltower

Welltower Inc. (NYSE:HCN), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience. Welltower™, a real estate investment trust (REIT), owns more than 1,400 properties in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties. More information is available at www.welltower.com.

EN
23/01/2017

Underlying

WELLWelltower Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Welltower Inc.

EUR 167.87
WELL WELLTOWER INC.

Moody's assigns Baa1 to Welltower's new convertible notes

Moody's Investors Service ("Moody's") assigned a Baa1 rating to Welltower OP LLC, the operating subsidiary of Welltower Inc. (collectively "Welltower" or "WELL" or "the REIT"), private offering of $750 million of backed senior unsecured convertible notes due 2028, which are not callable until after ...

05/08/23 May 8, 2023 1 EN
EUR 233.15
WELL WELLTOWER INC.

Welltower Inc.: Update to credit analysis

Our credit view of Welltower considers the strong balance sheet, good financial flexibility and high-quality portfolio, partially constrained by an elevated operating leverage.

04/21/23 April 21, 2023 1 EN
EUR 233.15
WELL WELLTOWER INC.

Welltower Inc.: Update to credit analysis

Our credit view of this issuer reflects its diversification by property type, geography and tenant / operator and its solid fixed charge coverage, constrained by its elevated leverage.

04/05/22 April 5, 2022 1 EN
EUR 233.15
WELL WELLTOWER INC.

Welltower Inc.: Update to credit analysis

Our credit view of Welltower reflects its high quality and diversified portfolio and solid fixed charge coverage, offset by its elevated leverage.

03/14/22 March 14, 2022 1 EN
Free Trial
WELL WELLTOWER INC.

An unfavourable environment weighs on WELLTOWER, which sees a downgrad...

The independent financial analyst theScreener just requalified the general evaluation of WELLTOWER (US), active in the Real Estate Investment Trusts industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as defensive. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Neutral. As of the analysis date February 18, 2022, the closin...

02/19/22 February 19, 2022 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch